Compounds > ranimustine
Page last updated: 2024-08-25

ranimustine and Primary Myelofibrosis

ranimustine has been researched along with Primary Myelofibrosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kubota, Y; Waki, M1
Fujita, H; Kurata, M; Maeda, A; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Takahashi, T; Tanaka, K; Tanaka, Y; Togami, K1
Harashima, S; Okamura, T; Takaki, K; Umeno, M1
Asano, Y; Kato, K; Okabe, H; Sanefuji, H; Shimokawa, M1
Abe, R; Kariyone, S; Matsuda, S; Matsuoka, R; Shiga, Y; Uchida, T1

Other Studies

5 other study(ies) available for ranimustine and Primary Myelofibrosis

ArticleYear
[Long-term remission of non-Hodgkin lymphoma secondary to the treatment for essential thrombocythemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:3

    Topics: Alkylating Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Nitrosourea Compounds; Primary Myelofibrosis; Remission Induction; Rituximab; Thrombocythemia, Essential; Time Factors

2009
Multiple granulocytic sarcomas in essential thrombocythemia.
    International journal of hematology, 2006, Volume: 84, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Etoposide; Fatal Outcome; Female; Femoral Fractures; Femoral Neoplasms; Humans; Hydroxyurea; Middle Aged; Mitobronitol; Neoplasm Metastasis; Nitrosourea Compounds; Primary Myelofibrosis; Radiography; Sarcoma, Myeloid; Thrombocythemia, Essential

2006
[A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Middle Aged; Nitrosourea Compounds; Polycythemia; Primary Myelofibrosis

1996
Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.
    Acta haematologica, 1991, Volume: 85, Issue:2

    Topics: Antineoplastic Agents; Humans; Male; Middle Aged; Nitrosourea Compounds; Primary Myelofibrosis; Splenomegaly

1991
[The use of MCNU to a patient of primary myelofibrosis complicated with pericardial effusion and proteinuria].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:4

    Topics: Aged; Antineoplastic Agents; Female; Humans; Nitrosourea Compounds; Pericardial Effusion; Primary Myelofibrosis; Proteinuria

1989